FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Pharmaceutical Ingredients Doxycycline Hyclate Recall

Doxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g packaged in a 500 c…

American Pharmaceutical Ingredients LLC · Waterford, MI

Risk level
Class II
Reported by FDA
Jul 5, 2017
Recall ID
D-0927-2017
Check your lot numberHow we source this data

Summary

American Pharmaceutical Ingredients recalled Doxycycline Hyclate starting Jun 1, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0927-2017 on Jul 5, 2017. Reason: Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient.

Product description

Doxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g packaged in a 500 cc container (NDC: 58597-8082-4), b) 100 g packaged in 16 oz container (NDC: 58597-8082-6), c) 500 g packaged in a 2500 cc container (NDC: 58597-8082-7) and a 1,000 g packaged in 1 gallon container (NDC: 58597-8082-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Lot numbers, UPCs & expiration codes

Lot: 082815-1, EXP 06/04/2019

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0927-2017
Classification
Class II
Status
Terminated
Recall initiated
Jun 1, 2017
FDA report date
Jul 5, 2017
Quantity
23.5kg
Recall type
Voluntary: Firm initiated
Recalling firm
American Pharmaceutical Ingredients LLC

Original FDA data

Every field from FDA enforcement report D-0927-2017, exactly as published.

Show all FDA fields
City
Waterford
State
MI
Status
Terminated
Country
United States
Event ID
77525
Address
6650 Highland Rd Ste 302
Code information
Lot: 082815-1, EXP 06/04/2019
Postal code
48327-1665
Report date
Jul 5, 2017
Product type
Drugs
Recall number
D-0927-2017
Classification
Class II
Recalling firm
American Pharmaceutical Ingredients LLC
Product quantity
23.5kg
Termination date
May 31, 2018
Reason for recall
Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Doxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g packaged in a 500 cc container (NDC: 58597-8082-4), b) 100 g packaged in 16 oz container (NDC: 58597-8082-6), c) 500 g packaged in a 2500 cc container (NDC: 58597-8082-7) and a 1,000 g packaged in 1 gallon container (NDC: 58597-8082-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327
Distribution pattern
Nationwide in the US
Recall initiation date
Jun 1, 2017
Initial firm notification
Telephone
Center classification date
Jun 29, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0927-2017, published Jul 5, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls